welcome to oneGRAVESvoice- a positively charged Graves' disease and thyroid eye disease community.
- join today!
- log in
Set in San Francisco’s Union Square, RARE in the Square brings together rare disease innovators each year to provide a unique opportunity to network with industry thought leaders and promote the role of patients as partners and drivers in rare disease drug development that lay the foundation for positive change in the rare disease space.
January 10 – 13, 2022
San Francisco, California, United States
This event has ended.
Risk Factors of Hepatic Dysfunction in Patients With Graves’ Hyperthyroidism and the Efficacy of 131iodine Tre...Hepatic dysfunction is often observed in...
Association of Radioactive Iodine Treatment With Cancer Mortality in Patients With HyperthyroidismImportance Radioactive iodine (RAI) h...
Randomized Trial of a Short Course of Preoperative Potassium Iodide in Patients Undergoing Thyroidectomy for Graves&...Background: A short course of potassium...
Treatment of Hyperthyroidism With Antithyroid Drugs Corrects Mild Neutropenia in Graves’ DiseaseContext: Neutropenia secondary to antit...
Predictive Score for the Development or Progression of Graves’ Orbitopathy in Patients With Newly Diagnosed Gr...Objective: To construct a predictive sc...
Selenium in Graves Hyperthyroidism and OrbitopathyPurpose: To review the in vitro and in ...
Montefiore Medical Center Comprehensive Thyroid ProgramThe highly experienced physicians with t...